INS and Hyperglycemia: With building evidence for no effect of oral or insulin treatment on glucose levels in GCK heterozygotes with mild hyperglycemia, identifying and terminating pharmaceutical treatments in these patients could lead to substantial lifestyle improvements and cost savings [23].